> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Generic User Fee Program Revised
- URL: https://www.fdaweb.com/info-collection-on-generic-user-fee-program-revised/
- Published: 2022-02-09T12:00:00.000Z
- Updated: 2026-09-14T17:32:04.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5151119

*Federal Register* notice: FDA has submitted to OMB an information collection revision entitled “Generic Drug User Fee Program” (OMB Control Number 0910-0727). The collection is being revised to include the current generic drug user fee agreement, or ‘‘goalsletter,’’ as reflected in the document “GDUFA Reauthorization Performance Goals and Program Enhancements Fiscal Years 2018–2022.” To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2022-02-09/pdf/2022-02689.pdf?ref=fdaweb.com).